Patents by Inventor Michal Margalith

Michal Margalith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Vaccinating Against HSV-2
    Publication number: 20100158949
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: October 16, 2009
    Publication date: June 24, 2010
    Applicants: VICAL INCORPORATED, THE UNIVERSITY OF WASHINGTON
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and Methods for Vaccinating Against HSV-2
    Publication number: 20100040651
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: October 23, 2009
    Publication date: February 18, 2010
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 7628993
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: December 8, 2009
    Assignees: Vical Incorporated, University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20080102087
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: July 20, 2007
    Publication date: May 1, 2008
    Applicants: Vical, Incorporated, University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Plasmids suitable for IL-2 expression
    Publication number: 20050065107
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Application
    Filed: October 15, 2004
    Publication date: March 24, 2005
    Inventors: Peter Hobart, Michal Margalith, Suezanne Parker, Shirin Khatibi
  • Plasmids suitable for IL-2 expression
    Publication number: 20030203863
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Application
    Filed: April 23, 2002
    Publication date: October 30, 2003
    Applicant: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Cancer treatment method utilizing plasmids suitable for IL-2 expression
    Patent number: 6399588
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: June 4, 2002
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Cancer treatment method utilizing plasmids suitable for IL-2 expression
    Patent number: 6147055
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: March 14, 1997
    Date of Patent: November 14, 2000
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Plasmids suitable for IL-2 expression
    Patent number: 5641665
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: June 24, 1997
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi